Expertise

FULL SERVICE

TRUSTED PARTNER

Intsel Chimos is your all in one pharmaceutical company with exploitant status in compliance with the French Public Health Code.

We support our partners in accessing the market for products under compassionate use, early access as well as marketing authorization of registered products. We are offering comprehensive expertise across the entire product life cycle:

  • Regulatory Affairs
  • Logistics & Supply Chain
  • Pharmacovigilance & Quality Assurance
  • Marketing & Sales

Intsel Chimos specializes in facilitating both early and market access, providing comprehensive support to pharmaceutical companies introducing therapies into the French healthcare system — both before and after marketing authorization. 

Additionally, Intsel Chimos can assist with data collection and product distribution within the framework of clinical trials.

OUR STRENGTHS

BENEFITS OF WORKING WITH INTSEL CHIMOS
Intsel Chimos offers a comprehensive and integrated approach to help pharmaceutical companies navigate complex regulatory and market environments. Key benefits include:

Integrated Services

From pharmacovigilance and quality assurance to strategic sales and marketing support, ensuring seamless product management and effective strategies.

Customized Strategies

Regulatory, pricing, and reimbursement solutions tailored to specific product and market objectives.

Continuity of Access

Full lifecycle management — from early access programs to post-marketing authorization — ensuring continuous patient access.

Compliance Excellence

Strict adherence to national and international standards (GVP, GMP, GDP, French Public Health Code).

Operational Efficiency

Optimized timelines and in-house storage and distribution securing the supply chain.

Cross-therapeutic Expertise:

Experience across multiple therapeutic areas, including rare diseases. 

OUR COMMITMENT

EFFICIENCY AND RELIABILITY
As a distributor and operator of compassionate and/or early access medicines (AAC/AAP), Intsel Chimos provides solutions for patients whose needs are unmet by treatments currently unavailable in the French market. 
  • COMPLIANCE AND LIABILITY :

Intsel Chimos has developed strong knowledge of the French and European healthcare systems and supports partners in navigating these environments across all therapeutic areas. 

  • REACTIVITY AND FLEXIBILITY :

The company has built capabilities enabling rapid and flexible acquisition and distribution of pharmaceutical products to hospitals and retail pharmacies. 

EXCELLENCE IN ACTION

As a pharmaceutical company, Intsel Chimos is committed to supporting the success of its partners at all stages: registration, market access, and promotion of treatments.

The objective is to achieve this in the simplest and most efficient way possible, while maintaining strict compliance with French and European regulations.

OUR PORTFOLIO

PRODUCTS

Intsel Chimos holds exploitant status across multiple therapeutic areas, from niche products to higher-volume medicines, providing a comprehensive offering to hospitals and pharmacies.

The company manages a portfolio of more than 80 products, covering both early access and commercial use.

PNEUMOLOGY

NEUROLOGY

CARDIOLOGY

ANESTHESIOLOGY

ONCOLOGY

INFECTIOLOGY

THERAPEUTIC AREAS